In the evolving landscape of biomedical cosmetics and precision skincare, CAS 154702-15-5, scientifically known as Dipeptide-2 (L-Valyl-L-tryptophan), stands as a cornerstone ingredient for lymphatic drainage and periorbital edema treatment. As a premier supplier and exporter, Aogebio LLC leverages decades of chemical expertise to provide pharmaceutical-grade Dipeptide-2 that meets the rigorous demands of global Tier-1 cosmetic brands.
This white paper explores the technical nuances, market dynamics, and future roadmap of Dipeptide-2, offering an "Information Gain" perspective for procurement officers and R&D formulation scientists.
CAS No: 154702-15-5. Molecular Formula: C16H21N3O3. Our production ensures a purity of ≥98.0% via HPLC analysis, with strictly controlled residual solvents and microbial counts.
Dipeptide-2 acts as an ACE (Angiotensin-Converting Enzyme) inhibitor. By inhibiting ACE, it improves lymphatic circulation and prevents fluid accumulation under the eyes.
Fully compliant with EU REACH, US FDA (VCRP), and China's NMPA (IECIC). We provide comprehensive SDS, COA, and Technical Data Sheets for seamless customs clearance.
The global eye care market is projected to reach USD 21.5 billion by 2028. Within this segment, the demand for anti-edema peptides like CAS 154702-15-5 has grown by 14% CAGR. Large-scale procurement is no longer limited to luxury brands but has permeated the "masstige" market.
We solve the "Stability Paradox." Dipeptide-2 is notoriously sensitive to pH fluctuations. Our proprietary stabilization technology ensures the peptide remains bioactive throughout a 24-month shelf life, even in aqueous formulations.
Our roadmap begins with the optimization of the coupling reaction between Valine and Tryptophan. We utilize Fmoc-protected amino acids to ensure zero racemization, maintaining the biological activity of the L-L isomer.
Raw synthesis products contain TFA salts and residual monomers. Our facility employs industrial-scale Preparative HPLC to achieve pharmaceutical-grade purity, reducing skin irritation potential to near zero.
Current industry trends favor "Active Cocktails." We provide solutions for Dipeptide-2 to be paired with Hesperidin Methyl Chalcone and Palmitoyl Tetrapeptide-7 (The Eyeliss™ concept) to triple the efficacy in lymphatic drainage.
Aogebio is currently investing in synthetic biology to produce CAS 154702-15-5 through yeast fermentation, aiming to reduce the carbon footprint by 40% by 2026.
Founded in 2013 and headquartered in the prestigious high-tech zone of Xi'an, Xi'an Aoge Biotech Co., Ltd., along with its subsidiaries Xi'an Imaherb Biotech Co., Ltd. and Xi'an Nahanutri Biotech Co., Ltd., has established itself as a leading force in the cosmetics raw materials industry.
Our expansive cooperative factory, spanning 1,000 mu (approximately 165 acres), is equipped with state-of-the-art extraction and synthesis technology. This advanced infrastructure allows us to manufacture a wide array of premium cosmetic raw materials including CAS:154702-15-5. Our product line includes natural plant extracts specifically designed for organic cosmetics, as well as synthetic ingredients for high-end skincare formulations.
Ensuring Reliability through Scientific Rigor
Our in-house lab uses advanced instruments like UPLC, HPLC, GC-MS, and ICP-MS for quality control, ensuring raw materials meet strict international standards for heavy metals, pesticide residues, and purity.
We pour relentless efforts into research and development, constantly exploring novel raw materials and advanced manufacturing techniques to stay ahead in the dynamic cosmetics industry.
We actively embrace sustainable practices, striving to minimize our environmental footprint through eco-friendly production methods and responsible sourcing of precursors for CAS:154702-15-5.
Rigorous quality control is embedded in every step of our production process, from raw material sourcing to final product delivery, guaranteeing adherence to ISO 9001 and GMP standards.
Aogebio Cosmetic
